| Joseph Eldon Ostler, MD, PHD | |
|
1840 Canyon Crest Dr, Twin Falls, ID 83301-3007 | |
| (208) 814-7100 | |
| (208) 814-7138 |
| Full Name | Joseph Eldon Ostler |
|---|---|
| Gender | Male |
| Speciality | Physical Medicine And Rehabilitation |
| Experience | 9 Years |
| Location | 1840 Canyon Crest Dr, Twin Falls, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235524802 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208100000X | Physical Medicine & Rehabilitation | M-17252 (Idaho) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Magic Valley Medical Center | Twin falls, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Clinic Llc | 1052217478 | 297 |
News Archive
A fruitful collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen.
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital.
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.
› Verified 8 days ago
| Entity Name | St Lukes Clinic Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790718229 PECOS PAC ID: 1052217478 Enrollment ID: O20031208000899 |
News Archive
A fruitful collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen.
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital.
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.
› Verified 8 days ago
| Entity Name | St Lukes Clinic-treasure Valley Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326336058 PECOS PAC ID: 4981878402 Enrollment ID: O20111119000045 |
News Archive
A fruitful collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen.
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital.
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Eldon Ostler, MD, PHD 1840 Canyon Crest Dr, Twin Falls, ID 83301-3007 Ph: (208) 814-7100 | Joseph Eldon Ostler, MD, PHD 1840 Canyon Crest Dr, Twin Falls, ID 83301-3007 Ph: (208) 814-7100 |
News Archive
A fruitful collaboration between chemists and biologists has made it possible to identify the effects of a new class of molecules, polyoxometalates, primarily composed of metals and oxygen.
Exposure to specific antibiotics is linked to the development of certain strains of antibiotic-resistant C. difficile, one of the fastest growing bacteria superbugs, according to a new study published by Stuart Johnson, MD, of Loyola University Health System, Loyola University Chicago Stritch School of Medicine and the Hines VA Medical Hospital.
Below are comments from Len Lichtenfeld, MD, American Cancer Society deputy chief medical officer, in response to the results of the STAR trial.
Soligenix, Inc., a late-stage biopharmaceutical company, announced today that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation to RiVax™ for the prevention of ricin intoxication. RiVax™ is a proprietary vaccine that contains a recombinant subunit of the A chain of ricin toxin which induces ricin neutralizing antibodies in humans and animals.
› Verified 8 days ago
Baylee Reiser, PT, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 625 Pole Line Rd W Ste 2b, Twin Falls, ID 83301 Phone: 208-814-5300 | |
Dr. Jonathan David Myers, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 738 N College Rd, Suite C, Twin Falls, ID 83301 Phone: 208-814-7100 | |
David Joseph Jensen, D.O. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 625 Pole Line Rd W Ste 1a, Twin Falls, ID 83301 Phone: 208-814-5250 | |
Cole Small, DPT Physical Medicine & Rehabilitation Medicare: Not Enrolled in Medicare Practice Location: 775 Pole Line Rd W, Twin Falls, ID 83301 Phone: 208-814-2570 | |
Dr. Jessica Lee Ziebarth, DO Physical Medicine & Rehabilitation Medicare: Medicare Enrolled Practice Location: 738 N College Rd, Suite C, Twin Falls, ID 83301 Phone: 208-814-7100 | |
Kim Cheri Wiggins, M.D. Physical Medicine & Rehabilitation Medicare: Accepting Medicare Assignments Practice Location: 738 N College Rd, Suite C, Twin Falls, ID 83301 Phone: 208-814-7100 Fax: 208-737-2731 |